NCT02779556

Brief Summary

The researchers will conduct a patient-randomized, pragmatic clinical trial among 6 rural PCMHs in Arkansas, targeting individuals with uncontrolled type 2 diabetes. The primary aims are to:

  1. 1.test the effectiveness of the ACP diabetes health literacy intervention to improve a range of diabetes-related outcomes among rural patients;
  2. 2.compared to usual care, evaluate whether the intervention reduces disparities by patient literacy level.
  3. 3.investigate whether a threshold or gradient effect exists between the amount of follow-up counseling (number of action plans) and intervention effectiveness;
  4. 4.determine the fidelity of all intervention components, and explore any identified patient, provider (physician, nurse, health coach), and/or health system barriers to implementation; and
  5. 5.assess the costs associated with implementing the intervention from a health system perspective.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
756

participants targeted

Target at P75+ for not_applicable diabetes

Timeline
Completed

Started Nov 2016

Typical duration for not_applicable diabetes

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 4, 2016

Completed
16 days until next milestone

First Posted

Study publicly available on registry

May 20, 2016

Completed
6 months until next milestone

Study Start

First participant enrolled

November 7, 2016

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 12, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 12, 2020

Completed
1.8 years until next milestone

Results Posted

Study results publicly available

December 15, 2021

Completed
Last Updated

December 15, 2021

Status Verified

December 1, 2021

Enrollment Period

3.3 years

First QC Date

May 4, 2016

Results QC Date

September 7, 2021

Last Update Submit

December 14, 2021

Conditions

Keywords

Health LiteracyDiabetes

Outcome Measures

Primary Outcomes (2)

  • Hemoglobin A1C (HbA1C)

    HbA1C will be obtained from patients' electronic health records, defined as the value closest to 6 months post baseline. The hemoglobin A1c (HbA1c) value ranges from approximately 4 to 14% where higher HbA1c value means worse outcome.

    Six months

  • Hemoglobin A1C (HbA1C)

    HbA1C will be obtained from patients' electronic health records, defined as the value closest to 12 months post baseline. The hemoglobin A1c (HbA1c) value ranges from approximately 4 to 14% where higher HbA1c value means worse outcome.

    Twelve months

Secondary Outcomes (2)

  • Diabetes Knowledge

    Three months

  • Diabetes Knowledge (0-13)

    Six months

Study Arms (2)

Enhanced Usual Care

OTHER

ADA Living Well with Diabetes Workbook, 15 minute in-person counseling, follow-up every 3 months

Other: ADA Living Well with Diabetes Workbook

Intervention

OTHER

ACP Living with Diabetes Guide, 15 minute in-person counseling , 15 minute follow-up counseling (3, 6, and 9 months), monthly phone calls after 3 months

Other: ACP Living with Diabetes Guide

Interventions

American Colleges of Physicians (ACP) Living Well with Diabetes Guide

Intervention

American Diabetes Association (ADA) Living Well with Diabetes Workbook

Enhanced Usual Care

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older
  • English speaking
  • active patient at regional family medical center study site
  • confirmed diagnosis of type 2 diabetes as documented in the electronic health record
  • recent Hemoglobin A1c reading of \>7.5% and less than or equal to 10%

You may not qualify if:

  • uncorrectable visual impairments
  • hearing impairments
  • cognitive impairments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

UAMS Family Medical Center Northwest

Fayetteville, Arkansas, 72703, United States

Location

UAMS Family Medical Center Fort Smith

Fort Smith, Arkansas, 72901, United States

Location

UAMS Family Medical Center Jonesboro

Jonesboro, Arkansas, 72401, United States

Location

UAMS Family Medical Center Magnolia

Magnolia, Arkansas, 71753, United States

Location

UAMS Family Medical Center Pine Bluff

Pine Bluff, Arkansas, 71603, United States

Location

UAMS Family Medical Center Texarkana

Texarkana, Arkansas, 71854, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Results Point of Contact

Title
Kristie Hadden, PhD/Associate Professor
Organization
University of Arkansas for Medical Sciences

Study Officials

  • Kristie Hadden, PhD

    University of Arkansas

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 4, 2016

First Posted

May 20, 2016

Study Start

November 7, 2016

Primary Completion

February 12, 2020

Study Completion

February 12, 2020

Last Updated

December 15, 2021

Results First Posted

December 15, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will share

The investigators are committed to the open and timely dissemination of the research outcomes. Plans for sharing resources with the scientific community include presentations and publications in peer-reviewed journals. The final data set will be made available to NIH investigators upon request. Consulting with program officer to ensure data sharing compliance.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
This will be available 6 months after publication of main study results.
Access Criteria
Require an NIH investigator with an IRB approved protocol, to conduct secondary data analysis of the available dataset.

Locations